List of insiders holdings for Denali Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | NELSEN ROBERT Director | 2021-06-04 18:35:30 | 18,654 9,668,749 | 9,687,403 | Form 4 |
| 2 | BIOGEN INC. Biogen MA Inc. 10% Owner | 2024-11-07 16:48:26 | 7,155,243 0 | 7,155,243 | Form 13G |
| 3 | FMR LLC See Remark 1 | 2026-05-06 11:13:07 | 6,672,999 0 | 6,672,999 | Form 13G |
| 4 | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 2024-02-13 16:27:05 | 5,750,882 0 | 5,750,882 | Form 13G |
| 5 | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 2024-02-13 16:27:05 | 5,750,882 0 | 5,750,882 | Form 13G |
| 6 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 2026-06-05 16:28:11 | 0 3,460,818 | 3,460,818 | Form 4 |
| 7 | Flagship Ventures Fund V L.P. AFEYAN NOUBAR Flagship Ventures Fund V General Partner LLC 10% Owner | 2021-02-16 17:08:00 | 2,730,263 0 | 2,730,263 | Form 13G |
| 8 | Watts Ryan J. President and CEO | 2026-01-08 16:20:05 | 296,833 2,152,604 | 2,449,437 | Form 4 |
| 9 | Tessier-Lavigne Marc Director | 2025-06-05 16:23:08 | 1,904,687 236,869 | 2,141,556 | Form 4 |
| 10 | FIL Ltd See Remark 1 | 2017-12-14 15:20:57 | 1,914,833 1,379 | 1,916,212 | Form 4 |
| 11 | Krognes Steve E. Director | 2026-06-05 16:45:43 | 57,428 781,797 | 839,225 | Form 4 |
| 12 | Schuth Alexander O. COFO and Secretary | 2026-01-08 16:19:45 | 282,828 523,749 | 806,577 | Form 4 |
| 13 | Ho Carole Chief Medical Officer | 2025-08-14 20:33:05 | 216,585 208,219 | 424,804 | Form 4 |
| 14 | FLATLEY JAY T Director | 2026-06-05 16:46:26 | 41,854 336,313 | 378,167 | Form 4 |
| 15 | Chin Peter Scott Chief Medical Officer | 2026-04-21 19:20:53 | 204,402 0 | 204,402 | Form 3/A |
| 16 | SATO VICKI L Director | 2025-01-03 16:13:51 | 107,976 0 | 107,976 | Form 4 |
| 17 | Schenkein David P Director | 2026-06-05 16:45:26 | 40,891 57,464 | 98,355 | Form 4 |
| 18 | Klein Peter S Director | 2026-06-05 16:45:59 | 53,167 0 | 53,167 | Form 4 |
| 19 | Cook Jennifer E. Director | 2026-06-05 16:43:24 | 51,709 0 | 51,709 | Form 4 |
| 20 | Thornberry Nancy Director | 2026-06-05 16:45:10 | 50,351 0 | 50,351 | Form 4 |
| 21 | Cole Douglas G. Director | 2023-06-05 18:01:14 | 39,213 0 | 39,213 | Form 4 |
| 22 | Van Hauwermeiren Timothy Director | 2026-06-05 16:44:52 | 36,266 0 | 36,266 | Form 4 |
| 23 | Harris Erik Director | 2024-06-04 18:27:58 | 34,953 0 | 34,953 | Form 4 |
| 24 | ARCH Venture Fund VIII L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH 10% Owner | 2022-02-08 15:04:10 | 0 0 | 0 | Form 13G |